This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: Wei Zeng: Innovator in Cancer Treatment
Introduction
Wei Zeng is a prominent inventor based in Carmel, IN (US). He has made significant contributions to the field of medical research, particularly in the development of therapies targeting cancer. With a total of 2 patents to his name, Zeng's work is paving the way for innovative treatments.
Latest Patents
Wei Zeng's latest patents focus on c-Met antibodies. These patents provide monoclonal antibodies, antigen-binding fragments, and combinations that bind to and inhibit the activity of c-Met. This innovation is effective in treating cancers and other diseases where pathogenesis is mediated by c-Met.
Career Highlights
Zeng is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to advancing healthcare. His work at Eli Lilly has allowed him to contribute to groundbreaking research and development in the field of oncology.
Collaborations
Some of Wei Zeng's notable coworkers include Julian Davies and Ling Liu. Their collaboration has fostered an environment of innovation and excellence in research.
Conclusion
Wei Zeng's contributions to cancer treatment through his patents and work at Eli Lilly and Company highlight his role as a key innovator in the medical field. His ongoing research promises to make a significant impact on the future of cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile